Samsung Biologics announced an all-cash tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share, implying equity value of about CHF 1.46 billion (KRW 2.706 trillion).
Korean translation
삼성바이오로직스가 주당 CHF 44.31, 약 CHF 14.6억(2조7,061억원) 규모의 현금 공개매수를 통해 PolyPeptide Group AG 인수를 발표함.